- In February 2024, the U.S.-based startup EnsoData, which specializes in artificial intelligence for data analysis in sleep medicine, obtained U.S. FDA approval for its AI-driven technology designed for sleep diagnosis using pulse oximeters
- In November 2023, Vivos expanded its range of sleep apnea products by receiving U.S. FDA approval for its Vivos CARE (complete airway repositioning and expansion) oral appliances, intended for patients suffering from obstructive sleep apnea (OSA)
- In July 2023, ResMed enhanced its global brand presence through the acquisition of Somnoware, a company providing sleep and respiratory diagnostics software
- In January 2023, Vivos broadened its product line for patients with mild-to-moderate obstructive sleep apnea by securing approval for its daytime-nighttime appliance, named DNA, as a Class II Device
- In October 2022, Acurable, a U.K.-based company specializing in wearable medical devices, raised USD 10.8 million to facilitate the global expansion of its offerings for at-home sleep apnea testing devices
